External Quality Controls

SARS Complete Panel

Respiratory Viral Panel

STI Panel

HPV Panel

Gastrointestinal Panel

ONBOARDx Kits

Proficiency Testing

Genital Ulcer Panel

DxTM Viral Transport Medium

Custom Vial Filling Solutions

Proudly Supporting Over 100+ Customers with Leading  Diagnostic Solutions 

Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™”

Gaetano Natale, Chief Commercial Officer.

The Microbix Difference

Our Quality Commitment

By choosing Microbix Biosystems Inc., you are aligning with a partner certified to the latest ISO standards and dedicated to delivering products that truly set the benchmark for quality in the industry.

Decades of Expertise

With over three decades of experience in the global diagnostics industry, Microbix has established a reputation as a leading infectious disease diagnostic manufacturer. 

Widespread Customer Acceptance

Microbix’s products have consistently earned widespread recognition and trust from customers due to their superior reliability. 

Download Our Full Product Catalogue 

News & Insights from Our Diagnostics Experts

  • Microbix & Bulgaria’s NCIPD Execute Supply Agreement

    Microbix & Bulgaria’s NCIPD Execute Supply Agreement

    Microbix Biosystems Inc. and the National Center for Infectious and Parasitic Diseases of Bulgaria (“NCIPD”), announce an agreement whereby NCIPD will supply a portfolio of pathogen seedstocks for production of Microbix quality assessment products (“QAPs™”).


  • Microbix Attending & Presenting at Asia Pacific POC 2025

    Microbix Attending & Presenting at Asia Pacific POC 2025

    Microbix Biosystems Inc. announces that it is attending and presenting at the 2nd Asia Pacific Conference on Point of Care Testing for Infectious Diseases, taking place in Bangkok, Thailand from 19 to 21 June, 2025 (“POC2025”).


  • Imagine there’s no cervical cancer. It’s easy, if we try.

    Imagine there’s no cervical cancer. It’s easy, if we try.

    In Ontario, health expenditures now exceed $87 billion per year and comprise over 40 per cent of overall spending. Such expenses are growing faster than our per capita productivity and show no signs of slowing down.


Speak to a Microbix Products Customer Service Representative

Let our knowledgeable experts help you secure your Microbix infectious disease diagnostics products supply today.